vs
NexPoint Real Estate Finance, Inc.（NREF）与Verastem, Inc.（VSTM）财务数据对比。点击上方公司名可切换其他公司
Verastem, Inc.的季度营收约是NexPoint Real Estate Finance, Inc.的1.0倍（$11.2M vs $11.1M），NexPoint Real Estate Finance, Inc.净利率更高（216.6% vs -876.3%，领先1093.0%）
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
Verastem, Inc.以Verastem Oncology品牌开展业务，是一家总部位于美国马萨诸塞州波士顿的制药企业，专注于开发抗癌治疗药物，该公司成立于波士顿，同时是纳斯达克生物技术指数成分股之一。
NREF vs VSTM — 直观对比
营收规模更大
VSTM
是对方的1.0倍
$11.1M
净利率更高
NREF
高出1093.0%
-876.3%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.1M | $11.2M |
| 净利润 | $24.0M | $-98.5M |
| 毛利率 | — | — |
| 营业利润率 | — | -362.2% |
| 净利率 | 216.6% | -876.3% |
| 营收同比 | -48.8% | — |
| 净利润同比 | 58.7% | -311.1% |
| 每股收益（稀释后） | $0.47 | $-1.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NREFVSTM
| Q4 25 | $11.1M | — | ||
| Q3 25 | $12.5M | $11.2M | ||
| Q2 25 | $12.1M | $2.1M | ||
| Q1 25 | $11.5M | — | ||
| Q4 24 | $21.7M | — | ||
| Q3 24 | $12.5M | $0 | ||
| Q2 24 | $6.7M | $10.0M | ||
| Q1 24 | $-12.8M | — |
净利润NREFVSTM
| Q4 25 | $24.0M | — | ||
| Q3 25 | $50.9M | $-98.5M | ||
| Q2 25 | $22.3M | $-25.9M | ||
| Q1 25 | $26.0M | — | ||
| Q4 24 | $15.2M | — | ||
| Q3 24 | $23.3M | $-24.0M | ||
| Q2 24 | $12.1M | $-8.3M | ||
| Q1 24 | $-14.6M | — |
营业利润率NREFVSTM
| Q4 25 | — | — | ||
| Q3 25 | — | -362.2% | ||
| Q2 25 | — | -2047.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -182.8% | ||
| Q1 24 | — | — |
净利率NREFVSTM
| Q4 25 | 216.6% | — | ||
| Q3 25 | 407.0% | -876.3% | ||
| Q2 25 | 184.5% | -1213.6% | ||
| Q1 25 | 225.6% | — | ||
| Q4 24 | 69.9% | — | ||
| Q3 24 | 186.4% | — | ||
| Q2 24 | 179.7% | -82.6% | ||
| Q1 24 | 114.3% | — |
每股收益（稀释后）NREFVSTM
| Q4 25 | $0.47 | — | ||
| Q3 25 | $1.14 | $-1.35 | ||
| Q2 25 | $0.54 | $-0.62 | ||
| Q1 25 | $0.70 | — | ||
| Q4 24 | $0.71 | — | ||
| Q3 24 | $0.74 | $-0.60 | ||
| Q2 24 | $0.40 | $-0.31 | ||
| Q1 24 | $-0.83 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.1M | $137.7M |
| 总债务越低越好 | $771.2M | — |
| 股东权益账面价值 | $388.0M | $-15.5M |
| 总资产 | $5.3B | $176.9M |
| 负债/权益比越低杠杆越低 | 1.99× | — |
8季度趋势，按日历期对齐
现金及短期投资NREFVSTM
| Q4 25 | $31.1M | — | ||
| Q3 25 | $17.9M | $137.7M | ||
| Q2 25 | $9.1M | $164.3M | ||
| Q1 25 | $19.2M | — | ||
| Q4 24 | $3.9M | — | ||
| Q3 24 | $34.7M | $113.2M | ||
| Q2 24 | $4.3M | $83.4M | ||
| Q1 24 | $13.5M | — |
总债务NREFVSTM
| Q4 25 | $771.2M | — | ||
| Q3 25 | $720.9M | — | ||
| Q2 25 | $815.6M | — | ||
| Q1 25 | $831.5M | — | ||
| Q4 24 | $799.3M | — | ||
| Q3 24 | $815.5M | $40.5M | ||
| Q2 24 | $861.0M | $40.3M | ||
| Q1 24 | $843.3M | — |
股东权益NREFVSTM
| Q4 25 | $388.0M | — | ||
| Q3 25 | $375.4M | $-15.5M | ||
| Q2 25 | $348.2M | $36.1M | ||
| Q1 25 | $343.7M | — | ||
| Q4 24 | $336.5M | — | ||
| Q3 24 | $335.8M | $11.1M | ||
| Q2 24 | $327.5M | $18.9M | ||
| Q1 24 | $327.1M | — |
总资产NREFVSTM
| Q4 25 | $5.3B | — | ||
| Q3 25 | $5.3B | $176.9M | ||
| Q2 25 | $5.4B | $196.3M | ||
| Q1 25 | $5.4B | — | ||
| Q4 24 | $5.4B | — | ||
| Q3 24 | $5.7B | $126.4M | ||
| Q2 24 | $6.6B | $105.7M | ||
| Q1 24 | $7.1B | — |
负债/权益比NREFVSTM
| Q4 25 | 1.99× | — | ||
| Q3 25 | 1.92× | — | ||
| Q2 25 | 2.34× | — | ||
| Q1 25 | 2.42× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 2.43× | 3.66× | ||
| Q2 24 | 2.63× | 2.14× | ||
| Q1 24 | 2.58× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.5M | $-36.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | -0.19× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NREFVSTM
| Q4 25 | $-4.5M | — | ||
| Q3 25 | $8.1M | $-36.2M | ||
| Q2 25 | $3.3M | $-32.7M | ||
| Q1 25 | $16.0M | — | ||
| Q4 24 | $4.4M | — | ||
| Q3 24 | $14.7M | $-23.8M | ||
| Q2 24 | $-7.5M | $-27.6M | ||
| Q1 24 | $17.7M | — |
自由现金流NREFVSTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-27.6M | ||
| Q1 24 | — | — |
自由现金流率NREFVSTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -275.8% | ||
| Q1 24 | — | — |
资本支出强度NREFVSTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | — |
现金转化率NREFVSTM
| Q4 25 | -0.19× | — | ||
| Q3 25 | 0.16× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.62× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.63× | — | ||
| Q2 24 | -0.62× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
